Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
47.6M
-
Shares change
-
+5.1M
-
Total reported value, excl. options
-
$681M
-
Value change
-
+$76.4M
-
Put/Call ratio
-
0.35
-
Number of buys
-
62
-
Number of sells
-
-40
-
Price
-
$14.32
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q4 2014
140 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q4 2014.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.6M shares
of 58.9M outstanding shares and own 80.83% of the company stock.
Largest 10 shareholders include FMR LLC (5.05M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.58M shares), BAKER BROS. ADVISORS LP (4.47M shares), DEERFIELD MANAGEMENT CO (4.14M shares), Palo Alto Investors, LLC (3.79M shares), PAULSON & CO INC (3.63M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2.46M shares), State Street Corp (1.88M shares), BlackRock Fund Advisors (1.55M shares), and MORGAN STANLEY (1.46M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.